ResearcherOkayama UniversityActive in the last 2 years
Yasuo Nagai
Matched on OpenAlex author ID A5113235407. Sources: OpenAlex.
Their work
- Papers
- 7
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2023: 1 paper · 2024: 1 paper · 2025: 3 papers · 2026: 2 papers
Papers 7
- Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. Co-author DOI 10.1016/j.omton.2026.201180↗
- p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. Co-author DOI 10.1038/s41417-025-00989-3↗
- Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppression by pirfenidone. Co-author DOI 10.1007/s00262-025-03946-z↗
- Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomic information. Co-author DOI 10.1186/s12935-025-03894-9↗
- Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers17203287↗
- Robot-Assisted Pancreaticoduodenectomy Using the Anterior Superior Mesenteric Artery-First Approach for Pancreatic Cancer. Co-author DOI 10.1245/s10434-024-16305-6↗
- [Therapeutic Effect of Oncolytic Adenovirus on Pancreatic Cancer Stroma]. Co-author PMID 38035844↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Toshiyoshi Fujiwara · 7 shared papers, 2023–2026 · strength 1.55
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Takeyoshi Nishiyama · 5 shared papers, 2024–2026 · strength 1.15
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Shinji Kuroda · 4 shared papers, 2023–2026 · strength 0.88
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppr… DOI 10.1007/s00262-025-03946-z↗
- Kosei Takagi · 4 shared papers, 2024–2025 · strength 0.87
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper Robot-Assisted Pancreaticoduodenectomy Using the Anterior Superior Mesenteric Artery-First Approach for Pancreatic Canc… DOI 10.1245/s10434-024-16305-6↗
- Paper Cancer-associated fibroblasts promote pro-tumor functions of neutrophils in pancreatic cancer via IL-8: potential suppr… DOI 10.1007/s00262-025-03946-z↗
- Yuzo Umeda · 3 shared papers, 2025–2026 · strength 0.67
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9↗
- Ryuichi Yoshida · 3 shared papers, 2025–2026 · strength 0.67
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9↗
- Kazuya Yasui · 3 shared papers, 2024–2025 · strength 0.66
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper Robot-Assisted Pancreaticoduodenectomy Using the Anterior Superior Mesenteric Artery-First Approach for Pancreatic Canc… DOI 10.1245/s10434-024-16305-6↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9↗
- Yoshinori Kajiwara · 2 shared papers, 2026 · strength 0.48
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Ryohei Shoji · 2 shared papers, 2026 · strength 0.48
- Paper Mitochondrial inhibition enhances the sensitivity of pancreatic ductal adenocarcinoma cells to oncolytic adenovirus. DOI 10.1016/j.omton.2026.201180↗
- Paper p53-armed oncolytic adenovirus induces apoptosis in pancreatic cancer-associated stellate cells via macropinocytosis. DOI 10.1038/s41417-025-00989-3↗
- Yuki Fujii · 2 shared papers, 2025 · strength 0.44
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9↗
- Kazuyuki Matsumoto · 2 shared papers, 2025 · strength 0.44
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9↗
- Motoyuki Otsuka · 2 shared papers, 2025 · strength 0.44
- Paper Impact of Neoadjuvant Chemotherapy with Gemcitabine Plus S-1 in Patients with Resectable Pancreatic Ductal Adenocarcino… DOI 10.3390/cancers17203287↗
- Paper Precise stratification of prognosis in pancreatic ductal adenocarcinoma patients based on pre- and postoperative genomi… DOI 10.1186/s12935-025-03894-9↗
- Shigeru Horiguchi · 1 shared paper, 2025 · strength 0.25
- Hiroyoshi Y. Tanaka · 1 shared paper, 2026 · strength 0.23
- Mitsunobu R. Kano · 1 shared paper, 2026 · strength 0.23
- Atsushi Masamune · 1 shared paper, 2026 · strength 0.23
- Kanto Suemori · 1 shared paper, 2025 · strength 0.21
- Tomohiko Yagi · 1 shared paper, 2025 · strength 0.21
- Shohei Nogi · 1 shared paper, 2025 · strength 0.21
- Kokichi Miyamoto · 1 shared paper, 2025 · strength 0.19
- Hironari Kato · 1 shared paper, 2025 · strength 0.19
- Kazuhiro Yoshida · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.